Cite
Issa D, Eghtesad B, Zein NN, et al. Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation. Int J Organ Transplant Med. 2016;7(1):38-45
Issa, D., Eghtesad, B., Zein, N. N., Yerian, L., Cruise, M., Alkhouri, N., Adams, R., & Hanouneh, I. A. (2016). Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation. International journal of organ transplantation medicine, 7(1), 38-45.
Issa, D, et al. "Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation." International journal of organ transplantation medicine vol. 7,1 (2016): 38-45.
Issa D, Eghtesad B, Zein NN, Yerian L, Cruise M, Alkhouri N, Adams R, Hanouneh IA. Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation. Int J Organ Transplant Med. 2016;7(1):38-45. Epub 2016 Feb 01. PMID: 26889372; PMCID: PMC4756263.
Copy
Download .nbib